Showing results (191-200 of 464) with videos related to

Sort By:
Pageof 47
Science (New York, N.Y.)|August 24, 1990
Suppression of human colorectal carcinoma cell growth by wild-type p53S J Baker, S Markowitz, E R Fearon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1995
Renal vein thrombosis treated with thrombolytic therapy: case report and brief reviewG S Markowitz, F Brignol, E R Burns, et al.
Pharmacological Research|February 21, 2012
Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant actionHao-Jie Zhu, David I Appel, Dirk Gründemann, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 10, 2012
C3 glomerulopathy masquerading as acute postinfectious glomerulonephritisGagangeet Sandhu, Anip Bansal, Aditi Ranade, et al.
Oncogene|August 19, 2014
TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivationS M Morris, K T Carter, J Y Baek, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteersJohn S Markowitz, Jennifer L Donovan, C Lindsay DeVane, et al.
Kidney International|April 17, 2004
Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrumM Barry Stokes, Glen S Markowitz, Julie Lin, et al.
Clinical Nephrology|February 28, 2002
Minimal change disease in systemic lupus erythematosusG K Dube, G S Markowitz, J Radhakrishnan, et al.
Biomedical Chromatography : BMC|January 26, 2012
A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samplesDavid I Appel, Bryan Brinda, John S Markowitz, et al.
Pageof 47